<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0005">
 <label>5</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Sulkowski</surname>
    <given-names>MS</given-names>
   </name>, 
   <name name-style="western">
    <surname>Cooper</surname>
    <given-names>C</given-names>
   </name>, 
   <name name-style="western">
    <surname>Hunyady</surname>
    <given-names>B</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C</article-title>. 
  <source>Nat Rev Gastroenterol Hepatol</source>
  <year>2011</year>;
  <volume>8</volume>:
  <fpage>212</fpage>–
  <lpage>23</lpage>.
  <pub-id pub-id-type="pmid">21386812</pub-id>
 </mixed-citation>
</ref>
